What does Atrium Therapeutics, Inc. do?

Atrium Therapeutics, Inc. is a public company in the Pharmaceutical Preparations industry, incorporated in DE. It is registered with the SEC under CIK 0002093101 and trades on NASDAQ under the ticker RNA.

How many SEC filings has Atrium Therapeutics, Inc. made?

Atrium Therapeutics, Inc. has filed 24 documents with the SEC since 2025. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Atrium Therapeutics, Inc.

RNA NASDAQ CIK: 0002093101 Pharmaceutical Preparations Inc. in DE

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 24 filings →

Form	Description	Date
4	4	Mar 2, 2026
4	4	Mar 2, 2026
4	4	Mar 2, 2026
4	4	Mar 2, 2026
4	4	Mar 2, 2026
8-K	8-K	Feb 27, 2026
3	3	Feb 26, 2026
3	3	Feb 26, 2026
3	3	Feb 26, 2026
3	3	Feb 26, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Atrium Therapeutics, Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0002093101
Ticker: RNA
Exchange: NASDAQ
Incorporated: DE
First Filing: 2025
Total Filings: 24

Pharmaceutical Preparations rankings →